Ensure Compliance with EU GMP Annex 1: STERIS Purefit™ Sterilization Wrapping
Fill out the form below to access the full white paper
Fill out the form below to access the full white paper
Pharmaceutical manufacturers face significant challenges in preventing contamination during sterile drug production. The European Union Good Manufacturing Practice (EU GMP) Annex 1 mandates a robust Contamination Control Strategy (CCS) to minimize these risks. Legacy wrapping methods often fall short, potentially leading to increased contamination risks, operational inefficiencies and regulatory non-compliance. STERIS Purefit™ Sterilization Wrapping offers reliability and compliance – effectively addressing these challenges.
This white paper, developed in collaboration with DuPont, explores the critical aspects of ensuring compliance with EU GMP Annex 1, including:
Our technical services team, comprised of industry-recognized scientists and engineers, provides exceptional expertise in contamination control strategies, process optimization, regulatory compliance, validation support and quality assurance. Navigate complex regulatory landscapes, reduce operational risks and accelerate your time-to-market with support from our professionals.
Meet the Team
STERIS is a leading global provider of products and services that support patient care with an emphasis on infection prevention.
© Copyright 2026, STERIS plc. All rights reserved.
Registered office: 70 Sir John Rogerson's Quay, Dublin 2 Ireland